Related Experiment Video

Updated: Jul 26, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Trends and challenges of multi-drug resistance in childhood tuberculosis

Zengfang Zhuang1,2, Lin Sun3, Xiaorui Song4

  • 1Chinese Academy of Sciences (CAS) Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Frontiers in Cellular and Infection Microbiology
|June 19, 2023
PubMed

Insights

Drug-resistant tuberculosis (DR-TB) in children is a growing global health concern. Improved diagnosis and treatment options are urgently needed for childhood DR-TB, including new drugs and biomarkers.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Childhood tuberculosis (TB) and drug-resistant TB (DR-TB) present significant global health challenges.
  • Accurate diagnosis and effective treatment of DR-TB in children are complex and evolving areas.
  • Current diagnostic tools and treatment regimens for pediatric DR-TB have notable limitations.

Purpose of the Study:

  • To review the current epidemiology of childhood TB and DR-TB.
  • To discuss diagnostic and treatment challenges for pediatric DR-TB.
  • To highlight the need for advancements in diagnosis and therapy.

Main Methods:

  • Comprehensive literature review of childhood TB and DR-TB.
  • Analysis of epidemiological data (prevalence, incidence, mortality).
  • Summary of challenges in diagnosis, treatment, and monitoring.

Main Results:

  • Childhood DR-TB is an increasing concern with complex diagnostic and treatment hurdles.
  • Existing diagnostic tools are limited for pediatric populations.
  • Current treatment options face challenges including adverse effects and prolonged durations.

Conclusions:

  • There is an urgent need for improved diagnostic strategies and novel therapeutic options for childhood DR-TB.
  • Further research into new drugs, drug combinations, and biomarkers is essential.
  • Advancements in diagnostics and treatment are critical to combatting pediatric DR-TB effectively.

Keywords:
childhood tuberculosisdiagnosticepidemiologymultidrug resistanttreatment

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.8K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
48
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
287
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175